Dan Liu
Director/Board Member at JIANGSU HUALAN NEW PHARMACEUTICAL MATERIAL CO.,LTD.
Network origin in Dan Liu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Containers/Packaging | 17 | |
| Public Company | Biotechnology | 13 | |
Genfleet Therapeutics (Shanghai), Inc.
 Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017.
11
| Holding Company | Miscellaneous Commercial Services | 11 |
Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd.
 Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. Medical SpecialtiesHealth Technology Wuxi Shenrui Bio-Pharmaceuticals Co., Ltd. is a private company that manufactures medical equipment. The company is based in Wuxi, China. The Chinese company was founded in 1999. The CEO is Qing Song Sheng.
5
| Private Company | Medical Specialties | 5 |
Innolake Pharmaceuticals (Hangzhou) Co., Ltd.
 Innolake Pharmaceuticals (Hangzhou) Co., Ltd. Pharmaceuticals: MajorHealth Technology Innolake Pharmaceuticals (Hangzhou) Co., Ltd. is a company based in Hangzhou, China that engages in the development and commercialization of therapeutic drugs for tumors and immune system diseases. The Chinese company was founded in 2020 by Ru Lei Chen and Ming De Xia, with Ming De Xia serving as the CEO since 2020.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dan Liu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| Stanford University | College/University | Graduate Degree | |
| ANGANG STEEL COMPANY LIMITED | Steel | Director/Board Member | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Doctorate Degree | |
| Auburn University | College/University | Doctorate Degree | |
| Yale University | College/University | Graduate Degree | |
| University of Illinois | College/University | Graduate Degree | |
| Nanjing University | College/University | Graduate Degree Doctorate Degree Doctorate Degree | |
| The University of Western Australia | College/University | Doctorate Degree | |
| Nanyang Technological University | College/University | Graduate Degree | |
| Tsinghua University | College/University | Masters Business Admin Graduate Degree | |
| Shanghai Jiao Tong University | College/University | Masters Business Admin | |
| Renmin University of China | College/University | Graduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Undergraduate Degree | |
| Hunan Normal University | College/University | Graduate Degree | |
| Central University of Finance & Economics | College/University | Undergraduate Degree | |
Citigroup Global Markets Asia Ltd.
 Citigroup Global Markets Asia Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors. | Investment Banks/Brokers | Corporate Officer/Principal | |
| JINLING HOTEL CORPORATION, LTD. | Hotels/Resorts/Cruise lines | Director/Board Member | |
| BANK OF NANJING CO., LTD. | Regional Banks | Director/Board Member | |
| Nanjing University of Aeronautics & Astronautics | College/University | Masters Business Admin | |
| Wuhan Polytechnic University | College/University | Undergraduate Degree | |
| China Pharmaceutical University | College/University | Graduate Degree | |
| HUASI HOLDING COMPANY LIMITED | Apparel/Footwear | Director/Board Member | |
| JIANGSU BAOLI INTERNATIONAL INVESTMENT CO., LTD. | Construction Materials | Director/Board Member | |
| SHENZHEN CHANGHONG TECHNOLOGY CO., LTD. | Containers/Packaging | Corporate Secretary | |
| AVIT LTD. | Telecommunications Equipment | Director/Board Member | |
| JIANGYIN JIANGHUA MICROELECTRONICS MATERIALS CO., LTD | Chemicals: Specialty | Director/Board Member | |
| GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Miscellaneous Manufacturing | Director/Board Member | |
| MICRO-TECH (NANJING) CO.,LTD | Medical Specialties | Founder | |
Genor Biopharma Co., Ltd.
 Genor Biopharma Co., Ltd. BiotechnologyHealth Technology Genor Biopharma Co., Ltd. engages in the manufacture and development of antibodies and related biological products. Its business scope includes research and development of monoclonal antibodies and biological products; research and development of instruments, equipment and reagents related to monoclonal antibodies and biological products; and wholesale, import and export of instruments, mechanical equipment, pharmaceutical equipment, and pharmaceutical intermediates. The company was founded on December 4, 2007 and is headquartered in Shanghai, China. | Biotechnology | Director/Board Member | |
| NANJING SINOLIFE UNITED COMPANY LIMITED | Pharmaceuticals: Other | Director/Board Member | |
| Hengyang Normal University | College/University | Undergraduate Degree | |
Shanghai Panlin Asset Management Co. Ltd.
 Shanghai Panlin Asset Management Co. Ltd. Investment ManagersFinance Shanghai Panlin Asset Management Co. Ltd. is a Private Equity and Venture Capital firm headquartered in Shanghai, China. The firm was established in 2010 founded by Yu Hui Li. | Investment Managers | Private Equity Investor | |
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
| LUOXIN PHARMACEUTICALS GROUP STOCK CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
| PHARMABLOCK SCIENCES (NANJING), INC. | Miscellaneous Commercial Services | Chief Executive Officer | |
| TANSUN TECHNOLOGY CO., LTD. | Packaged Software | Director/Board Member | |
| Shanghai Panxin Equity Investment Management Co. Ltd. | Chief Investment Officer | ||
| SHENZHEN YHLO BIOTECH CO., LTD. | Medical Specialties | Director/Board Member | |
| JIANGSU BIDE SCIENCE AND TECHNOLOGY CO.,LTD. | Industrial Machinery | Director/Board Member | |
| SUZHOU NANOMICRO TECHNOLOGY CO., LTD. | Miscellaneous Commercial Services | Director/Board Member | |
Suzhou Xiangyuan New Materials Co., Ltd.
 Suzhou Xiangyuan New Materials Co., Ltd. Chemicals: SpecialtyProcess Industries Suzhou Xiangyuan New Materials Co., Ltd. principally engages in the research, development, production, and sale of polyurethane chain extenders. Its key products are fine chemical products and new polyurethane chain extenders. The company was founded by Jian Zhou on July 3, 2001 and is headquartered in Suzhou, China. | Chemicals: Specialty | Director/Board Member | |
| BEIJING NEW SPACE TECHNOLOGY CO., LTD. | Engineering & Construction | Director/Board Member | |
| WUXI DK ELECTRONIC MATERIALS CO.,LTD. | Semiconductors | Director/Board Member | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Miscellaneous Commercial Services | Director/Board Member | |
| ZHAOKE OPHTHALMOLOGY LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| GENOR BIOPHARMA HOLDINGS LIMITED | Biotechnology | Director/Board Member | |
Aoran Biotechnology (Shanghai) Co. Ltd.
 Aoran Biotechnology (Shanghai) Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Aoran Biotechnology (Shanghai) Co. Ltd. is a biotechnology company based in Shanghai, China. Aoran Biotechnology specializes in molecular diagnostics. The Chinese company was founded in 2015 and the CEO is Chang Yu Jia. | Miscellaneous Commercial Services | Director/Board Member | |
| GUANGDONG LEARY NEW MATERIAL TECHNOLOGY CO.,LTD. | Containers/Packaging | Director/Board Member | |
| ORBUSNEICH MEDICAL GROUP HOLDINGS LIMITED | Medical Specialties | Director/Board Member | |
| NANJING MEDLANDER MEDICAL TECHNOLOGY CO.,LTD. | Medical Specialties | Director/Board Member |
Statistics
International
| China | 39 |
| United States | 5 |
| Hong Kong | 5 |
| Cayman Islands | 3 |
| Australia | 2 |
Sectoral
| Consumer Services | 20 |
| Health Technology | 11 |
| Process Industries | 5 |
| Commercial Services | 5 |
| Finance | 4 |
Operational
| Director/Board Member | 66 |
| Independent Dir/Board Member | 26 |
| Graduate Degree | 9 |
| Corporate Officer/Principal | 7 |
| Chairman | 7 |
Most connected contacts
| Insiders | |
|---|---|
| Yu Chen | 11 |
| Yi Zhou | 8 |
| Wei Guo Ma | 7 |
| Min Min Yang | 5 |
| Li Liu | 5 |
| Zuo Jun Xu | 4 |
| De Rong Leng | 4 |
| Bo Yu | 4 |
| Li Xin Yu | 4 |
| Bin Qing Xiao | 3 |
| Juan Du | 3 |
| Qiang Lü | 2 |
| Xing Bo Gu | 2 |
| Xiao Shan Jiao | 2 |
| Ling Wu Zeng | 2 |
- Stock Market
- Insiders
- Dan Liu
- Company connections
